Literature DB >> 2078522

In vivo expression of interleukin 5 induces an eosinophilia and expanded Ly-1B lineage populations.

D L Vaux1, P A Lalor, S Cory, G R Johnson.   

Abstract

In vitro, murine interleukin 5 (IL-5) acts as a colony-stimulating factor for eosinophils and induces B cells to proliferate and secrete antibody. In order to assess the biological effects of IL-5 in vivo, we transplanted lethally irradiated mice with bone marrow cells infected with a recombinant retrovirus bearing the IL-5 coding sequence. Within 2 weeks the peripheral blood of recipient mice exhibited a marked eosinophilia which persisted for at least 12 months, and an excess number of eosinophils was also evident in the bone marrow, spleen, liver, lung, and gut. Although no changes could be detected in the conventional B lymphocyte population, the peritoneum was replete with B cells characteristic of the Ly-1 lineage. Despite these expanded cell populations, mice remained healthy for 12 months after transplantation. These results suggest that IL-5 acts primarily on eosinophils and B cells of the Ly-1 lineage and that persistent overproduction of these cell types is not pathogenic.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078522     DOI: 10.1093/intimm/2.10.965

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  5 in total

Review 1.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

2.  Effect of different sensitizing doses of antigen in a murine model of atopic asthma.

Authors:  K Sakai; A Yokoyama; N Kohno; K Hiwada
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

3.  Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33.

Authors:  J D Rioux; V A Stone; M J Daly; M Cargill; T Green; H Nguyen; T Nutman; P A Zimmerman; M A Tucker; T Hudson; A M Goldstein; E Lander; A Y Lin
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

Review 4.  B-1 Cell Heterogeneity and the Regulation of Natural and Antigen-Induced IgM Production.

Authors:  Nicole Baumgarth
Journal:  Front Immunol       Date:  2016-09-09       Impact factor: 7.561

5.  Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.

Authors:  Bruce M Hall; Rachael M Hall; Giang T Tran; Catherine M Robinson; Paul L Wilcox; Prateek K Rakesh; Chuanmin Wang; Alexandra F Sharland; Nirupama D Verma; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.